66
Participants
Start Date
December 8, 2012
Primary Completion Date
June 29, 2016
Study Completion Date
June 29, 2016
AVI-7100 versus placebo
dose-escalating AVI-7100 versus placebo
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
National Institute of Allergy and Infectious Diseases (NIAID)
NIH